上海博研生物工程研究中心為您現(xiàn)貨提供*的產(chǎn)品與服務(wù)，本中心產(chǎn)品齊全，保證實(shí)驗(yàn)的有效性，提供，是您科研實(shí)驗(yàn)產(chǎn)品的一站式平臺(tái)，咨詢。！

產(chǎn)品名稱：*抗體,Anti-human Fibrinogen優(yōu)質(zhì)服務(wù)

中文名稱：*抗體

英文名稱：Anti-human Fibrinogen

產(chǎn)品編號(hào)：BYK-1240R

產(chǎn)品別名： FGA; FGA protein; FGB; FGG; Fib2; Fibrin alpha chain ;Fibrinogen A alpha polypeptide; Fibrinogen A alpha polypeptide chain; Fibrinogen alpha chain; Fibrinogen B alpha polypeptide; Fibrinogen beta chain; Fibrinogen G alpha polypeptide; Fibrinogen gamma chain; MGC104327; MGC119422; MGC119423; MGC119425; MGC120405; FIBA_HUMAN.

本公司另供應(yīng)“*抗體”的標(biāo)記有：Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.
產(chǎn)品規(guī)格：100ug/200ug
產(chǎn)品濃度： 1mg/1ml
抗體來源：兔源、鼠源、山羊
克 ?。簡慰寺】贵w、多克隆抗體
抗體類型：一抗
性 狀： 凍干粉或液體
保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

*抗體,Anti-human Fibrinogen優(yōu)質(zhì)服務(wù)技術(shù)說明，產(chǎn)品*，由于篇幅原因，更多信息請(qǐng)：
Anti-EAAT1/Glast（Excitatory amino acid transporters 1）  膠質(zhì)細(xì)胞*運(yùn)載蛋白1 抗體
Anti-EAAT2 （Excitatory amino acid transporters 2）  抗膠質(zhì)細(xì)胞*運(yùn)載蛋白2抗體
Anti-EAAT3（Excitatory amino acid transporters 3）  抗膠質(zhì)細(xì)胞*運(yùn)載蛋白3抗體
Anti-EBNA-3A （Epstein Barr nuclear antigens 3）  EB病毒核抗原-3A抗體
Anti-ECE1（Endothelin Converting Enzyme 1）  內(nèi)皮素轉(zhuǎn)化酶1抗體
Anti-ECE2（Endothelin Converting Enzyme 2）  抗內(nèi)皮素轉(zhuǎn)化酶2抗體
Anti-ECG2 （Esophagus cancer-related gene-2）  食道癌相關(guān)基因抗體
Anti-ECM1 （extracellular matrix protein 1）  細(xì)胞外基質(zhì)蛋白1抗體
Anti-ECP（eosinophil cationic protein）  抗嗜酸性粒細(xì)胞陽離子蛋白抗體
Anti-ED-1 （Ectodermal Dysplasia 1）  外胚層發(fā)育不良抗體
Anti-EDNR-A（Endothelin receptor type A）  抗內(nèi)皮素受體A抗體
Anti-EGFR （Epidemal growth factor receptor）  表皮生長因子受體抗體
Anti-EGF（Epidermal growth factor）to human  表皮生長因子抗體（人）
Anti-Socs 1/FITC 熒光素標(biāo)記細(xì)胞因子信號(hào)傳導(dǎo)抑制蛋白1抗體IgG
Anti-Socs 2/FITC 熒光素標(biāo)記細(xì)胞因子信號(hào)傳導(dǎo)抑制蛋白2抗體IgG
Anti-Socs 3/FITC 熒光素標(biāo)記細(xì)胞因子信號(hào)傳導(dǎo)抑制蛋白3抗體IgG
Anti-SOD1/FITC 熒光素標(biāo)記超氧化物歧化酶1抗體IgG

產(chǎn)品介紹： 

Fibrinogen is the main protein of blood coagulation system. It is a large protein and it consists of two identical subunits that contain three polypeptide chains: alpha, beta and gamma. All chains are connected with each other by a number of disulfide bonds. Fibrinopeptides A （1 to 16 amino acids） and B （1 to 17 amino acids） are released by thrombin from the N terminal parts of alpha and beta chains, respectively. In this way fibrinogen is converted into fibrin, which by means of polymerization forms a fibrin clot. Fibrinogen clotting underlies pathogenesis of MI, thromboembolism and thromboses of arteries and veins, since fibrin is the main substrate for thrombus formation. Fibrinogen activation is also involved in pathogenesis of inflammation, tumor growth and many other diseases. The normal fibrinogen concentration in plasma is about 3 mg/ml. The elevated level of fibrinogen in patient's blood is regarded as an independent risk factor for cardiovascular diseases. An increase in blood fibrinogen concentration was shown to be a strong predictor of coronary heart disease （Sonel A. et al, and Rapold H.J. et al）. All these facts make fibrinogen an important parameter in the diagnosis of cardiovascular diseases.